Renal care companies settle with FTC

Two renal care companies have settled with the Federal Trade Commission on charges that they'd be teamed up to eliminate competition in Rhode Island and southeast Massachusetts.  According to the FTC, Fresenius Medical Care and American Renal Associates conducted a transaction in which ARA would pay $1.6 million for Fresenius to close three clinics, while paying an addition $2.8 million to acquire the remaining five Fresenius clinics based in Rhode Island. The FTC has called this "a naked agreement to eliminate competition."

Under the terms of the consent order settling the case, both companies would be barred from divvying up territory or customers with other clinic operators. Also, ARA will have to let the FTC know if it plans to buy any clinics in the areas of Warwick, R.I. and Cranston.

To learn more about the agreement:
- read this Modern Healthcare item

Related Articles:
Study: Dialysis chains profit from higher Epogen use. Report
FTC approves Fresenius, RCG deal. Report
Renal Care hit with Medicare whistleblower suit. Report
SPOTLIGHT: ESRD patients fall into Part D "doughnut hole." Report

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.